B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome

Involvement of the <i>bcl</i> -2 Gene in Human Follicular Lymphoma

Yoshihide Tsujimoto, Jeffrey Cossman, Elaine S. Jaffe et al. · Science · 1985 · 1.8K citations

Life Sciences, Genetics, Molecular Genetics +16

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

Nathalie A. Johnson, Kerry J. Savage, Olga Ludkovski et al. · Blood · 2009 · 584 citations · Full text

Medicine, Hematology, Oncology +16

Rearrangement of <i>MYC</i> Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab

Sharon Barrans, Simon Crouch, Alex Smith et al. · Journal of Clinical Oncology · 2010 · 550 citations · Full text

Medicine, Hematology, Oncology +17

Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma

M Krámer, Jos Hermans, E.R. Wijburg et al. · Blood · 1998 · 490 citations

Medicine, Oncology, Pathology +15

B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma

Matija Snuderl, Olga Kolman, Yi‐Bin Chen et al. · The American Journal of Surgical Pathology · 2010 · 355 citations · Full text

Medicine, Hematology, Pathology +17